RUXOLITINIB

RUXOLITINIB was reported 73257 times

RUXOLITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DISEASE PROPENSITY 47 0.9400
1 BLOOD ERYTHROPOIETIN ABNORMAL 36 0.6429
2 AQUAGENIC PRURITUS 52 0.6341
3 BRONCHIOLITIS OBLITERANS SYNDROME 63 0.3600
4 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 60 0.3468
5 MYELOFIBROSIS 944 0.3119
6 PRIMARY MYELOFIBROSIS 96 0.2981
7 HAEMATOCRIT ABNORMAL 318 0.2585
8 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 42 0.2069
9 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 45 0.1837
10 MYELOPROLIFERATIVE NEOPLASM 120 0.1810
11 GRAFT VERSUS HOST DISEASE IN LIVER 115 0.1606
12 BLAST CELLS PRESENT 77 0.1601
13 POLYCYTHAEMIA VERA 131 0.1600
14 SPLENOMEGALY 1802 0.1537
15 HAEMATOCRIT INCREASED 345 0.1512
16 GRAFT VERSUS HOST DISEASE IN EYE 34 0.1472
17 GRAFT VERSUS HOST DISEASE IN LUNG 69 0.1444
18 PNEUMONIA ADENOVIRAL 28 0.1414
19 PLATELET COUNT ABNORMAL 798 0.1319
20 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 25 0.1316
21 BLOOD LACTATE DEHYDROGENASE ABNORMAL 84 0.1239
22 PLATELET COUNT INCREASED 1562 0.1197
23 SPLEEN DISORDER 196 0.1156
24 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 74 0.1128
25 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 103 0.1112
26 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 232 0.1089
27 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 39 0.1071
28 MEAN CELL VOLUME ABNORMAL 50 0.1059
29 PRODUCT AVAILABILITY ISSUE 2392 0.1049
30 RED BLOOD CELL COUNT ABNORMAL 150 0.1020
31 IRON OVERLOAD 109 0.1009
32 GRAFT VERSUS HOST DISEASE IN SKIN 210 0.0952
33 CHRONIC GRAFT VERSUS HOST DISEASE 341 0.0944
34 DISEASE RISK FACTOR 37 0.0920
35 INTERLEUKIN LEVEL INCREASED 49 0.0888
36 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 124 0.0878
37 ESSENTIAL THROMBOCYTHAEMIA 31 0.0840
38 APPLICATION SITE ACNE 41 0.0837
39 BLAST CELL COUNT INCREASED 87 0.0830
40 HAEMOGLOBIN ABNORMAL 502 0.0780
41 EARLY SATIETY 149 0.0765
42 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 100 0.0759
43 BLOOD COUNT ABNORMAL 1141 0.0752
44 GRAFT VERSUS HOST DISEASE 539 0.0749
45 ALVEOLAR PROTEINOSIS 43 0.0726
46 VITILIGO 170 0.0724
47 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 52 0.0723
48 BLOOD PRODUCT TRANSFUSION DEPENDENT 29 0.0689
49 HAEMOGLOBIN INCREASED 310 0.0679
50 FULL BLOOD COUNT INCREASED 80 0.0672
51 WHITE BLOOD CELL COUNT ABNORMAL 421 0.0659
52 PARVOVIRUS INFECTION 25 0.0619
53 VIRAL HAEMORRHAGIC CYSTITIS 44 0.0618
54 DISSEMINATED MUCORMYCOSIS 24 0.0609
55 ACUTE LEUKAEMIA 95 0.0588
56 ADENOVIRUS INFECTION 164 0.0565
57 DECREASED ACTIVITY 593 0.0549
58 BONE MARROW DISORDER 164 0.0542
59 RED BLOOD CELL COUNT INCREASED 146 0.0529
60 CYTOMEGALOVIRUS INFECTION REACTIVATION 228 0.0516
61 ACUTE GRAFT VERSUS HOST DISEASE 232 0.0506
62 PULMONARY MUCORMYCOSIS 26 0.0492
63 NEUROENDOCRINE CARCINOMA OF THE SKIN 47 0.0480
64 RED BLOOD CELL ABNORMALITY 46 0.0479
65 EPSTEIN-BARR VIRAEMIA 51 0.0460
66 BLOOD IRON INCREASED 83 0.0442
67 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 122 0.0441
68 BASOPHIL COUNT INCREASED 33 0.0435
69 THROMBOCYTOSIS 159 0.0433
70 ENTEROVIRUS INFECTION 37 0.0428
71 PRODUCT DISTRIBUTION ISSUE 366 0.0394
72 NECROTISING RETINITIS 25 0.0391
73 PRECANCEROUS CONDITION 26 0.0388
74 STENOTROPHOMONAS INFECTION 52 0.0383
75 FUSARIUM INFECTION 26 0.0371
76 INCREASED TENDENCY TO BRUISE 325 0.0353
77 WHITE BLOOD CELL COUNT INCREASED 1349 0.0351
78 SQUAMOUS CELL CARCINOMA 326 0.0346
79 POST HERPETIC NEURALGIA 48 0.0334
80 CRITICAL ILLNESS 26 0.0333
81 BK VIRUS INFECTION 112 0.0332
82 PLATELET DISORDER 83 0.0329
83 RED BLOOD CELL COUNT DECREASED 939 0.0328
84 SPLENIC INFARCTION 57 0.0326
85 FULL BLOOD COUNT ABNORMAL 339 0.0320
86 ENTEROCOCCAL BACTERAEMIA 33 0.0311
87 SECOND PRIMARY MALIGNANCY 255 0.0306
88 PARAINFLUENZAE VIRUS INFECTION 46 0.0302
89 SQUAMOUS CELL CARCINOMA OF SKIN 182 0.0301
90 CYTOPENIA 367 0.0299
91 HAEMOGLOBIN DECREASED 3001 0.0292
92 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 218 0.0290
93 LEUKAEMIA 267 0.0283
94 VIRAEMIA 39 0.0281
95 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 74 0.0278
96 WHITE BLOOD CELL DISORDER 74 0.0276
97 ACUTE MYELOID LEUKAEMIA 416 0.0267
98 BLOOD IRON ABNORMAL 26 0.0266
99 HAEMATOCRIT DECREASED 527 0.0265
100 SPLENECTOMY 30 0.0258
101 PLATELET COUNT DECREASED 2730 0.0256
102 FULL BLOOD COUNT DECREASED 514 0.0255
103 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 58 0.0247
104 CYTOMEGALOVIRUS VIRAEMIA 110 0.0247
105 PRODUCT PHYSICAL CONSISTENCY ISSUE 136 0.0245
106 PNEUMOCYSTIS JIROVECII INFECTION 29 0.0243
107 PRECANCEROUS SKIN LESION 35 0.0237
108 SKIN CANCER 507 0.0235
109 ENERGY INCREASED 137 0.0232
110 OBLITERATIVE BRONCHIOLITIS 30 0.0228
111 PNEUMONIA FUNGAL 89 0.0225
112 PRODUCT DEPOSIT 35 0.0225
113 SERUM FERRITIN INCREASED 117 0.0222
114 HAEMORRHAGIC DIATHESIS 78 0.0219
115 ACUTE MYELOID LEUKAEMIA RECURRENT 47 0.0219
116 BONE MARROW TRANSPLANT 40 0.0211
117 PRODUCT DOSE OMISSION 1369 0.0210
118 NIGHT SWEATS 675 0.0209
119 RED CELL DISTRIBUTION WIDTH INCREASED 87 0.0209
120 CYSTITIS HAEMORRHAGIC 84 0.0208
121 ASPERGILLUS INFECTION 136 0.0207
122 BLOOD DISORDER 165 0.0206
123 PNEUMONIA PSEUDOMONAL 31 0.0202
124 HEPATOMEGALY 195 0.0198
125 THROMBOTIC MICROANGIOPATHY 193 0.0198
126 HAEMATOTOXICITY 186 0.0196
127 BASAL CELL CARCINOMA 301 0.0193
128 DISEASE COMPLICATION 88 0.0192
129 BLOOD IRON DECREASED 228 0.0192
130 BLOOD URIC ACID INCREASED 108 0.0187
131 STEROID DIABETES 28 0.0187
132 HERPES SIMPLEX 118 0.0181
133 MYCOBACTERIUM AVIUM COMPLEX INFECTION 48 0.0179
134 ASPARTATE AMINOTRANSFERASE ABNORMAL 27 0.0177
135 SPLENIC RUPTURE 29 0.0176
136 PRODUCT DOSE OMISSION IN ERROR 499 0.0176
137 OFF LABEL USE 15250 0.0174
138 GOUT 312 0.0174
139 VARICELLA ZOSTER VIRUS INFECTION 36 0.0173
140 RHINOVIRUS INFECTION 67 0.0172
141 HEPATOSPLENOMEGALY 44 0.0171
142 LABORATORY TEST ABNORMAL 501 0.0170
143 PORTAL HYPERTENSION 52 0.0168
144 ANAEMIA 3164 0.0166
145 BRONCHOPULMONARY ASPERGILLOSIS 126 0.0162
146 DYSCHEZIA 49 0.0160
147 PRODUCT PHYSICAL ISSUE 321 0.0159
148 CONTUSION 1531 0.0159
149 INCREASED APPETITE 299 0.0156
150 JC VIRUS INFECTION 25 0.0156
151 NOCARDIOSIS 40 0.0156
152 DISCOURAGEMENT 36 0.0154
153 LEUKAEMIA RECURRENT 26 0.0154
154 CYTOMEGALOVIRUS INFECTION 255 0.0153
155 IRON DEFICIENCY 69 0.0153
156 HYPERURICAEMIA 63 0.0153
157 SCLERODERMA 55 0.0151
158 SERUM FERRITIN DECREASED 26 0.0150
159 STAPHYLOCOCCAL BACTERAEMIA 65 0.0149
160 VENOOCCLUSIVE DISEASE 37 0.0148
161 CHRONIC MYELOID LEUKAEMIA 68 0.0147
162 BLOOD LACTATE DEHYDROGENASE INCREASED 230 0.0145
163 LEUKOCYTOSIS 256 0.0141
164 BACTERIAL SEPSIS 46 0.0141
165 WOUND HAEMORRHAGE 52 0.0140
166 ILL-DEFINED DISORDER 845 0.0139
167 PNEUMONIA CYTOMEGALOVIRAL 27 0.0139
168 URINARY TRACT INFECTION BACTERIAL 35 0.0138
169 VENOOCCLUSIVE LIVER DISEASE 68 0.0138
170 IMMUNOSUPPRESSION 121 0.0137
171 PNEUMATOSIS INTESTINALIS 39 0.0137
172 MEAN CELL VOLUME INCREASED 35 0.0136
173 HAEMATOLOGICAL INFECTION 33 0.0135
174 FIBROSIS 41 0.0133
175 RESPIRATORY SYNCYTIAL VIRUS INFECTION 116 0.0133
176 ALANINE AMINOTRANSFERASE ABNORMAL 28 0.0133
177 EYE CONTUSION 28 0.0132
178 VARICES OESOPHAGEAL 40 0.0132
179 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 379 0.0129
180 STEM CELL TRANSPLANT 32 0.0128
181 GASTROINTESTINAL ULCER 28 0.0126
182 GENERAL PHYSICAL CONDITION ABNORMAL 85 0.0125
183 THROMBOCYTOPENIA 1392 0.0124
184 NEUTROPHIL COUNT ABNORMAL 35 0.0124
185 BLOOD POTASSIUM INCREASED 201 0.0124
186 ACTINIC KERATOSIS 32 0.0123
187 SKIN LESION 338 0.0123
188 OPTIC NEUROPATHY 26 0.0123
189 NAIL DISCOLOURATION 48 0.0122
190 EPSTEIN-BARR VIRUS INFECTION 76 0.0122
191 THERAPY PARTIAL RESPONDER 187 0.0120
192 MUCORMYCOSIS 31 0.0119
193 HYPOGAMMAGLOBULINAEMIA 78 0.0119
194 TRANSPLANT FAILURE 29 0.0118
195 TRANSFUSION 123 0.0117
196 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 59 0.0116
197 BONE PAIN 673 0.0115
198 ESCHERICHIA BACTERAEMIA 27 0.0115
199 CYTOMEGALOVIRUS COLITIS 26 0.0113
200 BLOOD IMMUNOGLOBULIN G DECREASED 28 0.0113
201 RENAL FUNCTION TEST ABNORMAL 52 0.0112
202 PORTAL VEIN THROMBOSIS 36 0.0111
203 HERPES ZOSTER 639 0.0111
204 TERMINAL STATE 74 0.0111
205 INFECTION SUSCEPTIBILITY INCREASED 24 0.0110
206 EPISTAXIS 819 0.0109
207 HERPES VIRUS INFECTION 63 0.0109
208 CACHEXIA 56 0.0109
209 BLOOD CREATININE ABNORMAL 37 0.0107
210 PROSTATOMEGALY 42 0.0107
211 MULTIPLE ORGAN DYSFUNCTION SYNDROME 301 0.0106
212 APPETITE DISORDER 70 0.0105
213 THERAPEUTIC RESPONSE UNEXPECTED 473 0.0105
214 PIGMENTATION DISORDER 65 0.0105
215 LICHENOID KERATOSIS 24 0.0105
216 BLOOD POTASSIUM ABNORMAL 28 0.0105
217 SKIN PAPILLOMA 42 0.0105
218 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 24 0.0103
219 HYPERPHAGIA 41 0.0103
220 GASTROINTESTINAL MOTILITY DISORDER 55 0.0103
221 ACUTE LYMPHOCYTIC LEUKAEMIA 29 0.0102
222 BLOOD CHOLESTEROL ABNORMAL 47 0.0102
223 DIZZINESS POSTURAL 98 0.0101
224 BLOOD BLISTER 31 0.0099
225 MONOCYTE COUNT INCREASED 36 0.0099
226 HAEMATOLOGICAL MALIGNANCY 28 0.0098
227 HAEMORRHAGE URINARY TRACT 25 0.0098
228 PNEUMONIA VIRAL 31 0.0097
229 ORGANISING PNEUMONIA 48 0.0097
230 ONYCHOCLASIS 66 0.0096
231 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 526 0.0096
232 PSEUDOMONAS INFECTION 82 0.0096
233 PRODUCT DOSE OMISSION ISSUE 2806 0.0095
234 FAECES HARD 37 0.0095
235 BLOOD TEST ABNORMAL 133 0.0095
236 KLEBSIELLA INFECTION 47 0.0093
237 BACTERAEMIA 110 0.0093
238 DYSPNOEA EXERTIONAL 349 0.0093
239 WHITE BLOOD CELL COUNT DECREASED 998 0.0092
240 INTERNAL HAEMORRHAGE 105 0.0092
241 MELANOCYTIC NAEVUS 40 0.0091
242 WEIGHT INCREASED 2023 0.0090
243 NEUTROPHIL COUNT INCREASED 92 0.0090
244 FUNGAL SKIN INFECTION 36 0.0089
245 SKIN ULCER 229 0.0088
246 ROSACEA 41 0.0088
247 ECCHYMOSIS 60 0.0087
248 INTERNATIONAL NORMALISED RATIO DECREASED 35 0.0086
249 FLATULENCE 485 0.0085
250 HEPATITIS B REACTIVATION 27 0.0085
251 IMMUNODEFICIENCY 125 0.0084
252 BRAIN HERNIATION 25 0.0084
253 STOMATITIS 507 0.0084
254 ORAL DISORDER 61 0.0083
255 HORDEOLUM 36 0.0083
256 SKIN HAEMORRHAGE 122 0.0082
257 MYOPATHY 71 0.0082
258 PULMONARY TUBERCULOSIS 35 0.0082
259 BACK DISORDER 133 0.0082
260 YELLOW SKIN 38 0.0081
261 THERAPEUTIC PRODUCT EFFECT DELAYED 37 0.0081
262 ENTEROCOCCAL INFECTION 39 0.0081
263 PULMONARY HAEMORRHAGE 63 0.0080
264 FATIGUE 6265 0.0080
265 IMMUNE SYSTEM DISORDER 106 0.0080
266 ONYCHOMYCOSIS 35 0.0080
267 BLOOD PRESSURE ABNORMAL 158 0.0079
268 SKIN DISORDER 265 0.0079
269 PROCEDURAL HAEMORRHAGE 31 0.0079
270 MOUTH HAEMORRHAGE 58 0.0079
271 INSURANCE ISSUE 120 0.0078
272 SKIN ABRASION 37 0.0078
273 DISEASE PROGRESSION 922 0.0078
274 ORAL HERPES 152 0.0078
275 ABNORMAL LOSS OF WEIGHT 53 0.0078
276 MUSCLE STRAIN 67 0.0077
277 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 47 0.0077
278 TONGUE ULCERATION 26 0.0077
279 FEBRILE NEUTROPENIA 502 0.0076
280 RESPIRATION ABNORMAL 52 0.0075
281 DRUG DOSE OMISSION 1247 0.0075
282 COVID-19 PNEUMONIA 89 0.0075
283 DEATH 6480 0.0075
284 PNEUMONIA BACTERIAL 69 0.0075
285 MASS 105 0.0075
286 DERMATITIS ATOPIC 396 0.0075
287 SCRATCH 79 0.0075
288 EXERCISE TOLERANCE DECREASED 43 0.0075
289 SKIN ATROPHY 43 0.0075
290 AORTIC STENOSIS 26 0.0075
291 BLOOD CHOLESTEROL INCREASED 347 0.0074
292 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 71 0.0074
293 PARANASAL SINUS DISCOMFORT 28 0.0074
294 GINGIVAL BLEEDING 101 0.0074
295 PETECHIAE 77 0.0074
296 LYMPHOCYTE COUNT INCREASED 24 0.0073
297 ACUTE RESPIRATORY FAILURE 141 0.0073
298 PANCYTOPENIA 409 0.0073
299 INTENTIONAL PRODUCT USE ISSUE 640 0.0073
300 BACTERIAL INFECTION 136 0.0073
301 PNEUMOCYSTIS JIROVECII PNEUMONIA 73 0.0073
302 IRON DEFICIENCY ANAEMIA 67 0.0073
303 EATING DISORDER 154 0.0072
304 POST PROCEDURAL HAEMORRHAGE 84 0.0072
305 PRODUCT TEMPERATURE EXCURSION ISSUE 37 0.0072
306 FLUID INTAKE REDUCED 36 0.0072
307 PERIPHERAL VASCULAR DISORDER 37 0.0072
308 HYPERTRIGLYCERIDAEMIA 42 0.0072
309 SKIN DISCOLOURATION 329 0.0072
310 MEMORY IMPAIRMENT 982 0.0071
311 DERMATITIS ACNEIFORM 43 0.0071
312 ESCHERICHIA URINARY TRACT INFECTION 30 0.0071
313 HEPATIC PAIN 30 0.0070
314 DIFFUSE LARGE B-CELL LYMPHOMA 54 0.0070
315 VIRAL INFECTION 233 0.0070
316 HAEMATOMA 181 0.0070
317 BRAIN FOG 109 0.0069
318 MOUTH ULCERATION 145 0.0069
319 ASTHENIA 2586 0.0069
320 PRODUCT SUPPLY ISSUE 49 0.0069
321 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1237 0.0069
322 PNEUMONIA 2204 0.0068
323 HYPERSOMNIA 195 0.0068
324 STAPHYLOCOCCAL INFECTION 224 0.0068
325 SPINAL STENOSIS 28 0.0068
326 GASTROENTERITIS VIRAL 122 0.0068
327 CHRONIC LYMPHOCYTIC LEUKAEMIA 32 0.0067
328 REBOUND EFFECT 76 0.0067
329 MALIGNANT MELANOMA 90 0.0067
330 SKIN LACERATION 73 0.0067
331 LIMB INJURY 182 0.0067
332 WEIGHT LOSS POOR 34 0.0066
333 ABDOMINAL DISTENSION 688 0.0066
334 NOCTURIA 80 0.0066
335 BENIGN PROSTATIC HYPERPLASIA 34 0.0066
336 RENAL DISORDER 302 0.0065
337 ABDOMINAL TENDERNESS 32 0.0064
338 FEELING OF DESPAIR 30 0.0064
339 MYELODYSPLASTIC SYNDROME 93 0.0064
340 SKIN INFECTION 72 0.0064
341 HEPATIC ENZYME ABNORMAL 32 0.0064
342 BLOOD UREA INCREASED 107 0.0064
343 SLUGGISHNESS 65 0.0064
344 NEPHROLITHIASIS 291 0.0063
345 ARTHROPOD BITE 47 0.0063
346 POOR PERIPHERAL CIRCULATION 27 0.0063
347 CLOSTRIDIUM DIFFICILE COLITIS 67 0.0063
348 BLOOD BILIRUBIN INCREASED 170 0.0063
349 SEPTIC SHOCK 273 0.0063
350 POST PROCEDURAL INFECTION 51 0.0063
351 PULMONARY THROMBOSIS 68 0.0062
352 MUCOSAL INFLAMMATION 163 0.0062
353 ABNORMAL FAECES 51 0.0062
354 INFECTION 899 0.0062
355 CORONAVIRUS INFECTION 41 0.0062
356 ONYCHOMADESIS 26 0.0062
357 PULMONARY HYPERTENSION 129 0.0062
358 HYPOALBUMINAEMIA 48 0.0062
359 SEPSIS 686 0.0061
360 BOWEL MOVEMENT IRREGULARITY 47 0.0061
361 POOR QUALITY SLEEP 132 0.0061
362 THROMBOSIS 491 0.0061
363 VITAMIN D DECREASED 52 0.0061
364 CYSTITIS 193 0.0061
365 SCAB 69 0.0060
366 RENAL CYST 48 0.0060
367 THERAPY CHANGE 59 0.0060
368 TOOTH INFECTION 79 0.0060
369 BONE MARROW FAILURE 121 0.0059
370 SKIN TIGHTNESS 28 0.0059
371 SKIN HYPERPIGMENTATION 51 0.0059
372 MUSCLE FATIGUE 25 0.0059
373 MUSCULOSKELETAL CHEST PAIN 91 0.0059
374 BLOOD CREATINE INCREASED 26 0.0059
375 COVID-19 1029 0.0059
376 CLOSTRIDIUM DIFFICILE INFECTION 127 0.0058
377 FRUSTRATION TOLERANCE DECREASED 47 0.0058
378 CARDIAC VALVE DISEASE 33 0.0058
379 FEELING COLD 160 0.0057
380 DRUG EFFECT LESS THAN EXPECTED 85 0.0057
381 POLLAKIURIA 239 0.0057
382 DRUG RESISTANCE 147 0.0057
383 LOCALISED INFECTION 138 0.0057
384 FLUID RETENTION 290 0.0057
385 SKIN MASS 38 0.0057
386 PANCREATIC DISORDER 28 0.0057
387 LIGAMENT RUPTURE 25 0.0057
388 HAEMORRHAGE 587 0.0056
389 HYPERTRANSAMINASAEMIA 39 0.0056
390 THERAPY NON-RESPONDER 252 0.0056
391 GLUCOSE TOLERANCE IMPAIRED 33 0.0056
392 EYE INFECTION 63 0.0056
393 HAEMOLYSIS 43 0.0056
394 DIARRHOEA HAEMORRHAGIC 52 0.0056
395 HEAD INJURY 176 0.0056
396 LOW DENSITY LIPOPROTEIN INCREASED 43 0.0055
397 ACUTE RESPIRATORY DISTRESS SYNDROME 98 0.0055
398 COAGULOPATHY 92 0.0055
399 URINARY TRACT INFECTION 941 0.0055
400 IMPAIRED HEALING 181 0.0055
401 FAECES SOFT 40 0.0055
402 ULCER HAEMORRHAGE 37 0.0055
403 LIVER FUNCTION TEST INCREASED 117 0.0054
404 ORAL PAIN 122 0.0054
405 CANDIDA INFECTION 92 0.0054
406 PROSTATIC DISORDER 30 0.0054
407 PULMONARY MASS 81 0.0054
408 VARICOSE VEIN 28 0.0054
409 SYNOVIAL CYST 25 0.0054
410 INFLUENZA 601 0.0054
411 CONSTIPATION 1173 0.0054
412 MENISCUS INJURY 33 0.0054
413 PERIPHERAL SWELLING 826 0.0054
414 ESCHERICHIA INFECTION 44 0.0053
415 BACK INJURY 58 0.0053
416 SCIATICA 85 0.0053
417 HYPERBILIRUBINAEMIA 55 0.0053
418 TOOTH DISORDER 118 0.0053
419 BLOOD SODIUM DECREASED 100 0.0053
420 APHTHOUS ULCER 41 0.0053
421 FUNGAL INFECTION 176 0.0053
422 GINGIVAL PAIN 42 0.0053
423 BLOOD TRIGLYCERIDES INCREASED 93 0.0053
424 VIRAL UPPER RESPIRATORY TRACT INFECTION 25 0.0053
425 LIGAMENT SPRAIN 52 0.0053
426 ILLNESS 540 0.0052
427 GLOMERULAR FILTRATION RATE DECREASED 64 0.0052
428 DECREASED IMMUNE RESPONSIVENESS 51 0.0052
429 STRESS FRACTURE 28 0.0052
430 MUSCLE SPASMS 949 0.0052
431 RESPIRATORY FAILURE 377 0.0052
432 HUNGER 72 0.0052
433 SEASONAL ALLERGY 73 0.0052
434 PATHOGEN RESISTANCE 47 0.0052
435 LYMPHOCYTE COUNT DECREASED 91 0.0051
436 NEUROPATHY PERIPHERAL 488 0.0051
437 DIZZINESS 2557 0.0051
438 RASH MACULAR 177 0.0051
439 ABDOMINAL DISCOMFORT 849 0.0051
440 JOINT INJURY 108 0.0051
441 DIVERTICULITIS 140 0.0050
442 NAIL DISORDER 44 0.0050
443 ULCER 80 0.0050
444 PULMONARY CONGESTION 66 0.0050
445 WOUND 139 0.0050
446 MENTAL STATUS CHANGES 138 0.0050
447 RIB FRACTURE 102 0.0050
448 CELLULITIS 248 0.0049
449 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 991 0.0049
450 TUMOUR LYSIS SYNDROME 43 0.0049
451 PERIPHERAL COLDNESS 67 0.0049
452 PRURITUS 1872 0.0049
453 SPINAL DISORDER 46 0.0049
454 FOOD POISONING 26 0.0048
455 GASTROINTESTINAL SOUNDS ABNORMAL 24 0.0048
456 UPPER RESPIRATORY TRACT INFECTION 223 0.0048
457 AUTOIMMUNE DISORDER 47 0.0048
458 RETINAL HAEMORRHAGE 34 0.0048
459 BLADDER DISORDER 47 0.0047
460 MICTURITION URGENCY 54 0.0047
461 HIP FRACTURE 152 0.0047
462 FAECES DISCOLOURED 102 0.0047
463 GASTROINTESTINAL INFECTION 42 0.0047
464 FEEDING DISORDER 95 0.0047
465 WEIGHT FLUCTUATION 49 0.0047
466 FURUNCLE 37 0.0047
467 DEPRESSED MOOD 246 0.0046
468 FALL 1548 0.0046
469 PULMONARY ALVEOLAR HAEMORRHAGE 26 0.0046
470 FAILURE TO THRIVE 24 0.0046
471 HEPATIC STEATOSIS 86 0.0046
472 BLOOD CREATININE INCREASED 298 0.0046
473 PYREXIA 1577 0.0046
474 TEMPERATURE INTOLERANCE 47 0.0046
475 TOOTH FRACTURE 50 0.0045
476 ASCITES 133 0.0045
477 SINUS DISORDER 89 0.0045
478 UPPER-AIRWAY COUGH SYNDROME 37 0.0045
479 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 37 0.0045
480 FLANK PAIN 42 0.0045
481 HAIR GROWTH ABNORMAL 31 0.0045
482 SENSITIVE SKIN 33 0.0045
483 PSYCHIATRIC SYMPTOM 33 0.0045
484 BALANCE DISORDER 386 0.0045
485 DRY EYE 222 0.0044
486 RENAL PAIN 47 0.0044
487 URINE ODOUR ABNORMAL 26 0.0044
488 MUSCULOSKELETAL DISCOMFORT 76 0.0044
489 LUNG INFILTRATION 39 0.0044
490 FEELING ABNORMAL 1057 0.0044
491 PALLOR 120 0.0044
492 APPLICATION SITE PRURITUS 100 0.0044
493 ARTHROPATHY 244 0.0044
494 PRODUCT USE IN UNAPPROVED INDICATION 1085 0.0044
495 OEDEMA 236 0.0043
496 HYPOXIA 153 0.0043
497 ORAL CANDIDIASIS 57 0.0043
498 LIVER DISORDER 191 0.0043
499 NASOPHARYNGITIS 789 0.0043
500 ARTHRITIS 335 0.0043
501 DIARRHOEA 2735 0.0042
502 HAEMOPTYSIS 118 0.0042
503 ANAL INCONTINENCE 38 0.0042
504 DYSURIA 155 0.0042
505 SINUS HEADACHE 25 0.0042
506 LIMB DISCOMFORT 130 0.0042
507 WEIGHT DECREASED 1171 0.0042
508 PAIN IN EXTREMITY 1234 0.0042
509 HEAD DISCOMFORT 74 0.0042
510 PRODUCT PRESCRIBING ISSUE 91 0.0042
511 ENTEROCOLITIS 24 0.0042
512 ABDOMINAL PAIN 964 0.0041
513 BRONCHITIS 305 0.0041
514 LUNG DISORDER 201 0.0041
515 NEUTROPHIL COUNT DECREASED 167 0.0041
516 INITIAL INSOMNIA 42 0.0041
517 DECREASED APPETITE 946 0.0041
518 DRUG INTOLERANCE 393 0.0041
519 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 29 0.0040
520 MACULAR DEGENERATION 48 0.0040
521 GASTROINTESTINAL HAEMORRHAGE 335 0.0040
522 OROPHARYNGEAL PAIN 371 0.0040
523 COLITIS 151 0.0040
524 PELVIC FRACTURE 31 0.0040
525 HEADACHE 2474 0.0039
526 EAR INFECTION 105 0.0039
527 WOUND INFECTION 43 0.0039
528 TOOTHACHE 71 0.0039
529 BODY TEMPERATURE INCREASED 80 0.0039
530 BLOOD ALBUMIN DECREASED 31 0.0039
531 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 278 0.0039
532 NEUTROPENIA 531 0.0039
533 BLOOD URINE PRESENT 74 0.0039
534 RENAL IMPAIRMENT 327 0.0039
535 DENTAL CARIES 43 0.0039
536 HEPATIC CIRRHOSIS 73 0.0039
537 MUSCLE ATROPHY 49 0.0039
538 CHILLS 451 0.0038
539 OESOPHAGITIS 42 0.0038
540 MALNUTRITION 43 0.0038
541 HYPOACUSIS 165 0.0038
542 GASTROINTESTINAL DISORDER 343 0.0038
543 BLOOD CALCIUM DECREASED 43 0.0038
544 KIDNEY INFECTION 75 0.0038
545 CARDIAC MURMUR 33 0.0038
546 EAR PAIN 74 0.0038
547 DIVERTICULUM 27 0.0038
548 COUGH 1060 0.0038
549 SLEEP DISORDER 266 0.0038
550 LYMPHADENOPATHY 133 0.0038
551 EYE HAEMORRHAGE 50 0.0037
552 PRODUCT USE COMPLAINT 59 0.0037
553 BLOOD ALKALINE PHOSPHATASE INCREASED 93 0.0037
554 EYE DISORDER 123 0.0037
555 NEOPLASM 43 0.0037
556 BACK PAIN 867 0.0037
557 RESPIRATORY TRACT INFECTION 97 0.0037
558 PNEUMOTHORAX 59 0.0037
559 HAEMATEMESIS 94 0.0037
560 MALAISE 1626 0.0037
561 ECZEMA 194 0.0037
562 EMOTIONAL DISORDER 114 0.0037
563 DRY MOUTH 300 0.0037
564 POST PROCEDURAL COMPLICATION 71 0.0037
565 ATRIAL FIBRILLATION 360 0.0037
566 NERVE COMPRESSION 34 0.0037
567 BLISTER 206 0.0037
568 DRY THROAT 37 0.0036
569 VERTIGO 221 0.0036
570 DISEASE RECURRENCE 172 0.0036
571 PLEURAL EFFUSION 219 0.0036
572 PULMONARY OEDEMA 161 0.0036
573 AUTOIMMUNE HEPATITIS 25 0.0036
574 GAIT INABILITY 120 0.0036
575 WRIST FRACTURE 43 0.0036
576 FOOT FRACTURE 68 0.0036
577 TRANSIENT ISCHAEMIC ATTACK 121 0.0036
578 SINUSITIS 366 0.0036
579 DRY SKIN 476 0.0036
580 INTESTINAL PERFORATION 40 0.0036
581 CARDIAC DISORDER 333 0.0036
582 LYMPHOMA 55 0.0036
583 DYSPNOEA 2011 0.0035
584 GENERAL PHYSICAL HEALTH DETERIORATION 411 0.0035
585 LYMPHOPENIA 50 0.0035
586 GROIN PAIN 31 0.0035
587 ORAL DISCOMFORT 49 0.0035
588 CEREBRAL DISORDER 26 0.0035
589 BONE DISORDER 64 0.0035
590 PRODUCT CONTAINER ISSUE 30 0.0035
591 APPLICATION SITE PAIN 77 0.0035
592 CONCUSSION 27 0.0035
593 CARDIAC FAILURE CONGESTIVE 280 0.0035
594 HAEMATURIA 119 0.0035
595 MUSCULAR WEAKNESS 394 0.0035
596 CYST 43 0.0035
597 DEHYDRATION 462 0.0035
598 ABDOMINAL PAIN UPPER 713 0.0035
599 TRANSAMINASES INCREASED 77 0.0035
600 HOSPICE CARE 34 0.0034
601 TINNITUS 158 0.0034
602 GASTRIC DISORDER 118 0.0034
603 THYROID DISORDER 53 0.0034
604 DYSPHONIA 201 0.0034
605 CEREBRAL HAEMORRHAGE 123 0.0034
606 DEMENTIA 96 0.0034
607 NEOPLASM MALIGNANT 229 0.0034
608 HAEMATOCHEZIA 188 0.0034
609 INCONTINENCE 36 0.0034
610 DYSPHAGIA 323 0.0034
611 ASPARTATE AMINOTRANSFERASE INCREASED 180 0.0034
612 PULMONARY EMBOLISM 321 0.0034
613 ACNE 256 0.0034
614 RETINAL DETACHMENT 31 0.0034
615 OEDEMA PERIPHERAL 411 0.0034
616 TENDERNESS 35 0.0034
617 SUNBURN 25 0.0033
618 MUSCLE DISORDER 27 0.0033
619 THINKING ABNORMAL 62 0.0033
620 NEPHROPATHY 31 0.0033
621 OSTEONECROSIS 109 0.0033
622 PNEUMONITIS 90 0.0033
623 TASTE DISORDER 67 0.0033
624 POLYURIA 27 0.0033
625 GAMMA-GLUTAMYLTRANSFERASE INCREASED 73 0.0033
626 SUBDURAL HAEMATOMA 47 0.0033
627 GLAUCOMA 63 0.0033
628 INSOMNIA 871 0.0033
629 MUSCULOSKELETAL PAIN 171 0.0033
630 PRODUCT DISPENSING ERROR 71 0.0033
631 CATARACT 194 0.0033
632 INFLAMMATION 168 0.0033
633 SOMNOLENCE 655 0.0032
634 UROSEPSIS 30 0.0032
635 ARTHRALGIA 1351 0.0032
636 HYPOPHAGIA 83 0.0032
637 ALANINE AMINOTRANSFERASE INCREASED 199 0.0032
638 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 55 0.0032
639 MYALGIA 550 0.0032
640 MYOSITIS 29 0.0032
641 ANKLE FRACTURE 50 0.0032
642 OSTEOPENIA 49 0.0032
643 HEPATIC ENZYME INCREASED 220 0.0032
644 DYSPEPSIA 316 0.0032
645 NEURALGIA 78 0.0032
646 DISCOMFORT 195 0.0032
647 INCORRECT DOSE ADMINISTERED 725 0.0032
648 SKIN FISSURES 62 0.0032
649 SMALL INTESTINAL OBSTRUCTION 39 0.0032
650 PERICARDIAL EFFUSION 73 0.0032
651 VITREOUS FLOATERS 31 0.0032
652 HEPATIC FAILURE 95 0.0031
653 GAIT DISTURBANCE 603 0.0031
654 BLOOD GLUCOSE ABNORMAL 58 0.0031
655 ABSCESS 50 0.0031
656 SKIN EXFOLIATION 264 0.0031
657 EAR DISCOMFORT 32 0.0031
658 DISTURBANCE IN ATTENTION 168 0.0031
659 ROTATOR CUFF SYNDROME 40 0.0031
660 SECRETION DISCHARGE 39 0.0031
661 GASTRIC ULCER 59 0.0031
662 ERUCTATION 60 0.0031
663 PAIN 1904 0.0031
664 ACCIDENT 37 0.0031
665 SPINAL FRACTURE 62 0.0031
666 MITRAL VALVE INCOMPETENCE 35 0.0031
667 MOBILITY DECREASED 222 0.0031
668 MELAENA 68 0.0031
669 LACERATION 29 0.0031
670 DYSSTASIA 90 0.0031
671 MYELOSUPPRESSION 111 0.0031
672 GASTRITIS 81 0.0031
673 SPINAL OSTEOARTHRITIS 27 0.0031
674 RENAL TUBULAR NECROSIS 30 0.0031
675 HERNIA 59 0.0030
676 HEPATITIS 78 0.0030
677 MUSCULOSKELETAL DISORDER 58 0.0030
678 TOOTH ABSCESS 31 0.0030
679 TREATMENT NONCOMPLIANCE 165 0.0030
680 UPPER LIMB FRACTURE 60 0.0030
681 EMBOLISM 25 0.0030
682 HYPOAESTHESIA 450 0.0030
683 RHINORRHOEA 194 0.0030
684 ATELECTASIS 29 0.0030
685 RASH 1307 0.0030
686 OROPHARYNGEAL DISCOMFORT 27 0.0030
687 DEVICE RELATED INFECTION 46 0.0030
688 RED BLOOD CELL SEDIMENTATION RATE INCREASED 33 0.0030
689 OSTEOMYELITIS 54 0.0030
690 RESTLESS LEGS SYNDROME 54 0.0030
691 PHOTOSENSITIVITY REACTION 49 0.0030
692 SINUS CONGESTION 40 0.0030
693 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 69 0.0030
694 FLUID OVERLOAD 43 0.0030
695 DECUBITUS ULCER 24 0.0029
696 RESPIRATORY DISORDER 88 0.0029
697 INTERVERTEBRAL DISC DEGENERATION 27 0.0029
698 DISSEMINATED INTRAVASCULAR COAGULATION 41 0.0029
699 NASAL CONGESTION 171 0.0029
700 MUSCLE TIGHTNESS 47 0.0029
701 RASH PRURITIC 157 0.0029
702 HYPERHIDROSIS 373 0.0029
703 BURNING SENSATION 203 0.0029
704 CARDIAC FAILURE 232 0.0029
705 EYE DISCHARGE 30 0.0029
706 GASTROENTERITIS 42 0.0029
707 CONDITION AGGRAVATED 875 0.0029
708 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 150 0.0029
709 HEPATOTOXICITY 64 0.0029
710 HAEMORRHOIDS 56 0.0029
711 HYPERTENSION 608 0.0029
712 VISUAL IMPAIRMENT 355 0.0029
713 BLOOD POTASSIUM DECREASED 86 0.0029
714 ENCEPHALOPATHY 70 0.0028
715 CARDIOMEGALY 35 0.0028
716 HYPERLIPIDAEMIA 34 0.0028
717 AMNESIA 185 0.0028
718 ALOPECIA 557 0.0028
719 QUALITY OF LIFE DECREASED 38 0.0028
720 ACUTE KIDNEY INJURY 432 0.0028
721 HYPERKALAEMIA 98 0.0028
722 APHONIA 39 0.0028
723 NAUSEA 2211 0.0028
724 HAEMOLYTIC ANAEMIA 25 0.0028
725 HEPATIC FUNCTION ABNORMAL 104 0.0028
726 LIVER FUNCTION TEST ABNORMAL 81 0.0028
727 GASTRIC HAEMORRHAGE 32 0.0028
728 FOLLICULITIS 29 0.0028
729 LIP DRY 25 0.0027
730 THIRST 49 0.0027
731 NECK PAIN 153 0.0027
732 UPPER GASTROINTESTINAL HAEMORRHAGE 46 0.0027
733 PANCREATITIS ACUTE 61 0.0027
734 LOWER LIMB FRACTURE 52 0.0027
735 JOINT SWELLING 326 0.0027
736 THERAPY INTERRUPTED 193 0.0027
737 INTERVERTEBRAL DISC PROTRUSION 59 0.0027
738 HYPERCHOLESTEROLAEMIA 26 0.0027
739 HEART RATE DECREASED 94 0.0027
740 RENAL FAILURE 355 0.0027
741 MALIGNANT NEOPLASM PROGRESSION 271 0.0026
742 AGEUSIA 66 0.0026
743 PRODUCTIVE COUGH 125 0.0026
744 OSTEOPOROSIS 107 0.0026
745 CONJUNCTIVITIS 48 0.0026
746 SWELLING 242 0.0026
747 NEPHROPATHY TOXIC 29 0.0026
748 RESPIRATORY TRACT CONGESTION 41 0.0026
749 GALLBLADDER DISORDER 46 0.0026
750 LUNG INFECTION 40 0.0026
751 CHOLELITHIASIS 84 0.0026
752 PRODUCT USE ISSUE 481 0.0026
753 PULMONARY FIBROSIS 49 0.0026
754 HAIR TEXTURE ABNORMAL 34 0.0025
755 LEUKOPENIA 127 0.0025
756 TREATMENT FAILURE 208 0.0025
757 BLOOD PRESSURE FLUCTUATION 60 0.0025
758 FEELING HOT 153 0.0025
759 HOT FLUSH 188 0.0025
760 LETHARGY 143 0.0025
761 OXYGEN SATURATION DECREASED 139 0.0025
762 HIATUS HERNIA 32 0.0025
763 GASTROOESOPHAGEAL REFLUX DISEASE 198 0.0025
764 INTERSTITIAL LUNG DISEASE 119 0.0025
765 LACRIMATION INCREASED 74 0.0024
766 HYPOTHYROIDISM 78 0.0024
767 PRODUCT PRESCRIBING ERROR 58 0.0024
768 CHOLECYSTITIS 29 0.0024
769 SARS-COV-2 TEST POSITIVE 32 0.0024
770 MIGRAINE 231 0.0024
771 APHASIA 73 0.0024
772 HOSPITALISATION 371 0.0024
773 SLEEP APNOEA SYNDROME 46 0.0024
774 CYTOKINE RELEASE SYNDROME 48 0.0024
775 DERMATITIS 50 0.0024
776 DEPRESSION 541 0.0024
777 CONFUSIONAL STATE 384 0.0024
778 MIDDLE INSOMNIA 44 0.0024
779 ORTHOSTATIC HYPOTENSION 41 0.0024
780 CHROMATURIA 53 0.0023
781 VOMITING 1103 0.0023
782 APATHY 34 0.0023
783 PARAESTHESIA 366 0.0023
784 GLOSSODYNIA 52 0.0023
785 CHEST PAIN 428 0.0023
786 PHARYNGITIS STREPTOCOCCAL 25 0.0023
787 SPINAL PAIN 27 0.0023
788 THERAPEUTIC RESPONSE DECREASED 139 0.0023
789 CEREBROVASCULAR ACCIDENT 388 0.0023
790 PRESCRIBED OVERDOSE 44 0.0023
791 FRACTURE 43 0.0023
792 DEEP VEIN THROMBOSIS 147 0.0023
793 GENERALISED OEDEMA 28 0.0023
794 RASH ERYTHEMATOUS 108 0.0023
795 C-REACTIVE PROTEIN INCREASED 82 0.0023
796 OBSTRUCTIVE AIRWAYS DISORDER 25 0.0022
797 PHOTOPHOBIA 42 0.0022
798 BURSITIS 27 0.0022
799 ADRENAL INSUFFICIENCY 27 0.0022
800 ROAD TRAFFIC ACCIDENT 93 0.0022
801 DEAFNESS 58 0.0022
802 SHOCK 51 0.0022
803 COLON CANCER 33 0.0022
804 VISION BLURRED 302 0.0022
805 ASPIRATION 24 0.0022
806 RECTAL HAEMORRHAGE 94 0.0022
807 MENTAL IMPAIRMENT 53 0.0022
808 SNEEZING 49 0.0022
809 GASTROINTESTINAL PAIN 24 0.0022
810 CARDIOMYOPATHY 32 0.0022
811 PROCEDURAL PAIN 60 0.0022
812 SKIN IRRITATION 99 0.0022
813 PAIN OF SKIN 58 0.0022
814 CHOKING 42 0.0022
815 ELECTROLYTE IMBALANCE 25 0.0021
816 EXTRA DOSE ADMINISTERED 87 0.0021
817 FREQUENT BOWEL MOVEMENTS 58 0.0021
818 RASH MACULO-PAPULAR 47 0.0021
819 ANXIETY 601 0.0021
820 INTENTIONAL DOSE OMISSION 60 0.0021
821 COLD SWEAT 37 0.0021
822 HYPOTENSION 419 0.0021
823 JOINT RANGE OF MOTION DECREASED 28 0.0021
824 PNEUMONIA ASPIRATION 52 0.0021
825 CHRONIC KIDNEY DISEASE 158 0.0021
826 HAEMORRHAGE INTRACRANIAL 31 0.0021
827 ISCHAEMIC STROKE 37 0.0021
828 DIABETES MELLITUS 158 0.0021
829 PULMONARY ARTERIAL HYPERTENSION 30 0.0021
830 HEART RATE INCREASED 205 0.0021
831 RETCHING 44 0.0021
832 COGNITIVE DISORDER 96 0.0021
833 RESPIRATORY DISTRESS 56 0.0020
834 HYPERCALCAEMIA 25 0.0020
835 IRRITABLE BOWEL SYNDROME 43 0.0020
836 DIPLOPIA 52 0.0020
837 BLOOD PRESSURE INCREASED 304 0.0020
838 BEDRIDDEN 26 0.0020
839 WITHDRAWAL SYNDROME 83 0.0020
840 PALPITATIONS 230 0.0020
841 HEART RATE IRREGULAR 44 0.0019
842 PROTEINURIA 37 0.0019
843 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 138 0.0019
844 ACUTE MYOCARDIAL INFARCTION 57 0.0019
845 JAUNDICE 52 0.0019
846 APPLICATION SITE IRRITATION 24 0.0019
847 URINARY INCONTINENCE 57 0.0019
848 THROAT IRRITATION 86 0.0019
849 NODULE 25 0.0019
850 BLINDNESS 78 0.0019
851 SPEECH DISORDER 100 0.0019
852 HYPOCALCAEMIA 36 0.0019
853 HYPERGLYCAEMIA 69 0.0019
854 CARDIOVASCULAR DISORDER 48 0.0019
855 ANGINA PECTORIS 54 0.0019
856 HEPATIC CYTOLYSIS 24 0.0019
857 CORONARY ARTERY DISEASE 57 0.0019
858 TOOTH LOSS 39 0.0019
859 METASTASES TO LIVER 33 0.0019
860 LOWER RESPIRATORY TRACT INFECTION 85 0.0019
861 MOVEMENT DISORDER 60 0.0019
862 INTERNATIONAL NORMALISED RATIO INCREASED 53 0.0019
863 HYPONATRAEMIA 104 0.0018
864 MENTAL DISORDER 80 0.0018
865 BLOOD PRESSURE DECREASED 122 0.0018
866 PAIN IN JAW 52 0.0018
867 OCULAR HYPERAEMIA 87 0.0018
868 JOINT STIFFNESS 48 0.0018
869 ACUTE HEPATIC FAILURE 25 0.0018
870 CENTRAL NERVOUS SYSTEM LESION 25 0.0018
871 INFLUENZA LIKE ILLNESS 149 0.0018
872 TENDONITIS 28 0.0018
873 DYSGEUSIA 134 0.0018
874 NERVOUSNESS 94 0.0018
875 TREMOR 298 0.0018
876 OSTEOARTHRITIS 76 0.0018
877 RASH PAPULAR 40 0.0018
878 DRUG INTERACTION 282 0.0018
879 HYPOKALAEMIA 82 0.0018
880 URINARY RETENTION 59 0.0018
881 CRYING 64 0.0018
882 PANCREATITIS 93 0.0018
883 SYNCOPE 176 0.0018
884 FEMUR FRACTURE 54 0.0017
885 ANOSMIA 25 0.0017
886 EYE PRURITUS 58 0.0017
887 DRUG INEFFECTIVE 2265 0.0017
888 DISORIENTATION 68 0.0017
889 CARPAL TUNNEL SYNDROME 24 0.0017
890 LOSS OF CONSCIOUSNESS 219 0.0017
891 MEDICATION ERROR 95 0.0017
892 BLOOD GLUCOSE DECREASED 82 0.0017
893 INTESTINAL OBSTRUCTION 64 0.0017
894 CHEST DISCOMFORT 173 0.0017
895 PRESYNCOPE 40 0.0016
896 ERYTHEMA 335 0.0016
897 ABDOMINAL PAIN LOWER 41 0.0016
898 DYSARTHRIA 61 0.0016
899 TACHYCARDIA 142 0.0016
900 SWOLLEN TONGUE 49 0.0016
901 EXPIRED PRODUCT ADMINISTERED 52 0.0016
902 APPLICATION SITE ERYTHEMA 41 0.0016
903 ABNORMAL DREAMS 43 0.0016
904 TYPE 2 DIABETES MELLITUS 52 0.0015
905 EYE PAIN 87 0.0015
906 HYPERSENSITIVITY 283 0.0015
907 FEAR 41 0.0015
908 TOXICITY TO VARIOUS AGENTS 255 0.0015
909 GLYCOSYLATED HAEMOGLOBIN INCREASED 38 0.0015
910 NERVOUS SYSTEM DISORDER 46 0.0015
911 CARDIAC ARREST 120 0.0015
912 MUSCULOSKELETAL STIFFNESS 127 0.0014
913 BLOOD PRESSURE SYSTOLIC INCREASED 28 0.0014
914 MUSCLE TWITCHING 33 0.0014
915 EOSINOPHILIA 25 0.0014
916 LIVER INJURY 35 0.0014
917 HEMIPARESIS 24 0.0014
918 MYOCARDIAL INFARCTION 247 0.0014
919 SEIZURE 163 0.0014
920 DRUG ERUPTION 25 0.0014
921 METABOLIC ACIDOSIS 44 0.0014
922 LUNG NEOPLASM MALIGNANT 56 0.0014
923 SWELLING FACE 86 0.0013
924 AGRANULOCYTOSIS 24 0.0013
925 LIP SWELLING 43 0.0013
926 PRODUCT ADMINISTRATION ERROR 26 0.0013
927 MOOD ALTERED 35 0.0013
928 ARRHYTHMIA 60 0.0013
929 PERITONITIS 26 0.0013
930 IRRITABILITY 75 0.0012
931 DELIRIUM 43 0.0012
932 EYE IRRITATION 71 0.0012
933 MOOD SWINGS 39 0.0012
934 ANGER 41 0.0012
935 DRUG ADMINISTRATION ERROR 37 0.0012
936 CEREBRAL INFARCTION 29 0.0012
937 SKIN BURNING SENSATION 84 0.0012
938 CARDIO-RESPIRATORY ARREST 49 0.0012
939 WHEEZING 68 0.0011
940 THERAPEUTIC RESPONSE SHORTENED 38 0.0011
941 BLOOD GLUCOSE INCREASED 215 0.0011
942 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 29 0.0011
943 PANIC ATTACK 41 0.0011
944 ASTHMA 126 0.0011
945 EYE SWELLING 41 0.0011
946 LACTIC ACIDOSIS 35 0.0011
947 THERAPEUTIC PRODUCT EFFECT DECREASED 48 0.0011
948 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 51 0.0011
949 ELECTROCARDIOGRAM QT PROLONGED 37 0.0010
950 ADVERSE DRUG REACTION 92 0.0010
951 NIGHTMARE 35 0.0010
952 UNRESPONSIVE TO STIMULI 26 0.0010
953 URTICARIA 165 0.0010
954 THERAPY CESSATION 50 0.0010
955 NO ADVERSE EVENT 176 0.0010
956 ABASIA 24 0.0010
957 DRUG-INDUCED LIVER INJURY 30 0.0010
958 INTENTIONAL PRODUCT MISUSE 82 0.0009
959 WRONG TECHNIQUE IN DRUG USAGE PROCESS 34 0.0009
960 INJURY 65 0.0009
961 DYSKINESIA 36 0.0009
962 ANAPHYLACTIC REACTION 48 0.0009
963 COMA 41 0.0009
964 SURGERY 50 0.0009
965 VAGINAL HAEMORRHAGE 37 0.0009
966 EPILEPSY 26 0.0008
967 AGITATION 62 0.0008
968 HALLUCINATION 63 0.0008
969 HYPOGLYCAEMIA 39 0.0008
970 PROSTATE CANCER 64 0.0008
971 RESTLESSNESS 28 0.0008
972 COLITIS ULCERATIVE 33 0.0007
973 BLADDER CANCER 43 0.0007
974 PRODUCT STORAGE ERROR 63 0.0007
975 BRADYCARDIA 38 0.0007
976 MATERNAL EXPOSURE DURING PREGNANCY 63 0.0007
977 ADVERSE EVENT 62 0.0007
978 PLASMA CELL MYELOMA 26 0.0007
979 BREAST CANCER 56 0.0006
980 FLUSHING 57 0.0006
981 DRUG WITHDRAWAL SYNDROME 46 0.0005
982 ACCIDENTAL EXPOSURE TO PRODUCT 54 0.0005
983 UNEVALUABLE EVENT 39 0.0005
984 INJECTION SITE SWELLING 34 0.0004
985 INJECTION SITE BRUISING 29 0.0004
986 RHEUMATOID ARTHRITIS 41 0.0004
987 INJECTION SITE PAIN 110 0.0004
988 SUICIDAL IDEATION 29 0.0003
989 PSORIASIS 38 0.0003
990 EMOTIONAL DISTRESS 32 0.0003
991 OVERDOSE 32 0.0001